Rankings
▼
Calendar
SCYX FY 2023 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$38M
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$140M
+2652.7% YoY
Gross Profit
$125M
88.9% margin
Operating Income
$73M
51.9% margin
Net Income
$67M
47.8% margin
EPS (Diluted)
$1.39
Cash Flow
Operating Cash Flow
$60M
Free Cash Flow
$60M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$128M
Total Liabilities
$55M
Stockholders' Equity
$73M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$140M
$5M
+2652.7%
Gross Profit
$125M
$4M
+2690.0%
Operating Income
$73M
-$86M
+184.7%
Net Income
$67M
-$63M
+206.7%
← Q4 2022
All Quarters
Q1 2023 →